Trial intelligence / Profile preview

Trazodone for Sleep Disturbance in Early Alcohol Recovery

NCT00027053Phase 2Completed

Sponsor
Rhode Island Hospital
Start
Jun 2002
Primary completion
Jan 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in alcohol dependence comparing Trazodone with Placebo (2 arms). Primary endpoint: Percent days abstinent from alcohol at 24 weeks. Started Jun 2002; status: completed.

02

Drugs

trazodone
03

Conditions

alcohol dependence

Beyond the preview

Go deeper on NCT00027053.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00027053.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call